Your browser doesn't support javascript.
loading
Collaborative AI and Laboratory Medicine integration in precision cardiovascular medicine.
Gruson, Damien; Bernardini, Sergio; Dabla, Pradeep Kumar; Gouget, Bernard; Stankovic, Sanja.
Afiliação
  • Gruson D; Department of Clinical Biochemistry, Cliniques Universitaires St-Luc and Université Catholique de Louvain, Brussels, Belgium; Pôle de recherche en Endocrinologie, Diabète et Nutrition, Institut de Recherche Expérimentale et Clinique, Cliniques Universitaires St-Luc and Université Catholique de Louva
  • Bernardini S; Department of Experimental Medicine, University of Tor Vergata, Rome, Italy; Emerging Technologies Division-MHBLM Committee, International Federation Clinical Chemistry and Laboratory Medicine (IFCC), Italy.
  • Dabla PK; Department of Biochemistry, G.B Pant Institute of Postgraduate Medical Education & Research, Associated to Maulana Azad Medical College, New Delhi, India; Emerging Technologies Division-MHBLM Committee, International Federation Clinical Chemistry and Laboratory Medicine (IFCC), Italy.
  • Gouget B; President-Healthcare Division Committee, Comité Français d'accréditation (Cofrac), 75012 Paris, France; Emerging Technologies Division-MHBLM Committee, International Federation Clinical Chemistry and Laboratory Medicine (IFCC), Italy.
  • Stankovic S; Center for Medical Biochemistry, Clinical Center of Serbia, Belgrade, Serbia; Emerging Technologies Division-MHBLM Committee, International Federation Clinical Chemistry and Laboratory Medicine (IFCC), Italy.
Clin Chim Acta ; 509: 67-71, 2020 Oct.
Article em En | MEDLINE | ID: mdl-32505771
ABSTRACT
Artificial Intelligence (AI) is a broad term that combines computation with sophisticated mathematical models and in turn allows the development of complex algorithms which are capable to simulate human intelligence such as problem solving and learning. It is devised to promote a significant paradigm shift in the most diverse areas of medical knowledge. On the other hand, Cardiology is a vast field dealing with diseases relating to the heart, the circulatory system, and includes coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions. AI has emerged as a promising tool in cardiovascular medicine which is aimed in augmenting the effectiveness of the cardiologist and to extend better quality to patients. It has the ability to support decision­making and improve diagnostic and prognostic performance. Attempt has also been made to explore novel genotypes and phenotypes in existing cardiovascular diseases, improve the quality of patient care, to enablecost-effectiveness with reducereadmissionand mortality rates. Our review addresses the integration of AI and laboratory medicine as an accelerator of personalization care associated with the precision and the need of value creation services in cardiovascular medicine.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Sistema Cardiovascular / Medicina de Precisão Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Chim Acta Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Sistema Cardiovascular / Medicina de Precisão Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Chim Acta Ano de publicação: 2020 Tipo de documento: Article